This author has not written his bio yet.
But we are proud to say that Andrew Humphreys contributed 3897 entries already.
BioNTech SE could have capacity to make 3 billion doses of the Covid-19 vaccine the company developed with partner Pfizer Inc. during 2022, Bloomberg News reported on March 9, citing an interview with the German company’s chief executive officer.
The White House said on March 9 that the government will distribute around 18.5 million doses of Covid-19 vaccines this week, fewer than last week because no new doses of Johnson & Johnson’s vaccine are ready to be sent out.
Takeda Pharmaceutical is advancing the Japanese pharma giant’s immune-oncology portfolio through the acquisition of the immunotherapy pioneer Maverick Therapeutics.
Cryoport Inc. appointed creative communications agency Mind+Matter, an Ashfield Health company and part of UDG Healthcare, as the company’s strategic marketing partner to support the rebrand of the entire business alongside a strategic communications plan.
Prescription drug watchdog GoodRx compiled a list of the 10 most expensive drugs on the market.
Clarivate published the company’s annual “Drugs to Watch” list, and cited several medicines that the analysts expect to be blockbusters – projected to bring in $1 billion in sales annually.
Johnson & Johnson told the European Union the company is facing supply issues that may complicate plans to deliver 55 million doses of J&J’s Covid-19 vaccine to the bloc in the second quarter of 2021, an EU official told Reuters.
Russia’s Sputnik V could be produced in western Europe for the first time after a deal to make the Covid-19 vaccine in Italy was signed by the RDIF sovereign wealth fund and Swiss-based pharmaceutical company Adienne.
Novartis’ drug canakinumab (ACZ885) did not meet the primary endpoint of overall survival in patients with advanced or metastatic non-small cell lung cancer in a Phase III study, but other late-stage trials are ongoing.
VUE Health filled four strategic senior leadership positions: Matthew West as VP, Human Resources Director, Eyrin Pena, MD, as Medical Director, Amy Knierim as Editorial Director, and Dan Platz as Account Director.
